Generic Product News (June 2017)

Pharmacy Times, June 2017 Women's Health, Volume 83, Issue 6

Read about the new generic products featured in June.

VITAMIN D3 10,000 IU

MARKETED BY: Nnodum Pharmaceuticals

COMPARE TO: Vitamin D

INDICATION: Nnodum has introduced Vitamin D3 10,000 IU to solve dosing issues associated with vitamin D and provide supplementation. Vitamin D3 is more bioavailable than any form of vitamin D and is easy to titrate, depending on the patient’s therapeutic level.

DOSAGE FORM: 30-count soft-gel capsule bottle

FOR MORE INFORMATION: nnodumpharma.com

OXYCODONE AND ACETAMINOPHEN TABLETSMARKETED BY: Camber Pharmaceuticals

COMPARE TO: Percocet (Endo Pharmaceuticals Inc)

INDICATION: Camber has announced the launch of its Oxycodone and Acetaminophen Tablets, USP, the generic version of Percocet tablets, for the treatment of moderate to moderately severe pain.

DOSAGE FORM: Tablets: 2.5/325 mg, 5/325 mg, 7.5/325 mg, and 10/325 mg

FOR MORE INFORMATION: camberpharma.com

MOMETASONE FUROATE NASAL SPRAYMARKETED BY: Amneal Pharmaceuticals LLC

COMPARE TO: Nasonex (Merck & Co, Inc)

INDICATION: Amneal has launched Mometasone Furoate Nasal Spray, 50 mcg, an AB-rated equivalent to Nasonex. Nasonex is used to treat nasal symptoms of seasonal or yearround allergies, including congestion, sneezing, and runny nose.

DOSAGE FORM: Nasal spray: 50 mcg/spray

FOR MORE INFORMATION: amneal.com

TAZAROTENE TOPICAL CREAMCOMPARE TO: Tazorac (Allergan)

MARKETED BY: Taro Pharmaceuticals

INDICATION: Taro Pharmaceuticals launched an AB-rated generic version of Tazorac (tazarotene) 0.1% topical cream. Tazorac 0.1% is indicated for the topical treatment of patients with plaque psoriasis and acne vulgaris.

DOSAGE FORM: Cream: 0.1%

FOR MORE INFORMATION: taro.com